Alonso A, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2): e000102.
Article PubMed PubMed Central Google Scholar
Attia ZI, et al. Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction. Nat Med. 2022;28(12):2497–503.
Article CAS PubMed PubMed Central Google Scholar
Attia ZI, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet. 2019;394(10201):861–7.
Cai W, et al. Accurate detection of atrial fibrillation from 12-lead ECG using deep neural network. Comput Biol Med. 2020;116: 103378.
Connolly SJ, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51.
Article CAS PubMed Google Scholar
Cox J, et al. Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial. Am Heart J. 2024;273:102–10.
Davidson KW, et al. Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement. Jama. 2022;327(4):360–7.
Duan J, et al. Accurate detection of atrial fibrillation events with R-R intervals from ECG signals. PLoS One. 2022;17(8): e0271596.
Article CAS PubMed PubMed Central Google Scholar
Feuerriegel S, et al. Causal machine learning for predicting treatment outcomes. Nat Med. 2024;30(4):958–68.
Article CAS PubMed Google Scholar
Gadaleta M, et al. Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias. NPJ Digit Med. 2023;6(1):229.
Article PubMed PubMed Central Google Scholar
Giugliano RP, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–104.
Article CAS PubMed Google Scholar
Glasgow RE, et al. The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial. Trials. 2021;22(1):528.
Article PubMed PubMed Central Google Scholar
Granger CB, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–92.
Article CAS PubMed Google Scholar
Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.
Ho PM, Bull S. Personalized patient data and behavioral nudges to improve adherence to chronic cardiovascular medications (The Nudge Study); 2023. Retrieved 6/22/2024, from https://dcricollab.dcri.duke.edu/sites/NIHKR/KR/GR-Slides-11-17-23.pdf.
Hygrell T, et al. An artificial intelligence-based model for prediction of atrial fibrillation from single-lead sinus rhythm electrocardiograms facilitating screening. Europace. 2023;25(4):1332–8.
Article PubMed PubMed Central Google Scholar
Kent DM, et al. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ 363. https://www.bmj.com/content/363/bmj.k4245
Khurshid S, et al. ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation. Circulation. 2022;145(2):122–33.
Article CAS PubMed Google Scholar
Kini V, Ho PM. Interventions to Improve Medication Adherence: A Review. Jama. 2018;320(23):2461–73.
Komen JJ, et al. Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. Eur Heart J. 2022;43(37):3528–38.
Article CAS PubMed PubMed Central Google Scholar
Kong D, et al. A novel IRBF-RVM model for diagnosis of atrial fibrillation. Comput Methods Programs Biomed. 2019;177:183–92.
Lee S, et al. Artificial Intelligence for Detection of Cardiovascular-Related Diseases from Wearable Devices: A Systematic Review and Meta-Analysis. Yonsei Med J. 2022;63(Suppl):S93–s107.
Article PubMed PubMed Central Google Scholar
Li YG, et al. A Simple Clinical Risk Score (C(2)HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. Chest. 2019;155(3):510–8.
Lopes RD, et al. Apixaban versus aspirin according to CHA2DS2-VASc score in subclinical atrial fibrillation: Insights from ARTESiA. J Am Coll Cardiol. 2024;84(4):354–64.
Lown M, et al. Machine learning detection of Atrial Fibrillation using wearable technology. PLoS One. 2020;15(1): e0227401.
Article CAS PubMed PubMed Central Google Scholar
Lubitz SA, et al. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study. Circulation. 2022;146(19):1415–24.
Article PubMed PubMed Central Google Scholar
Lubitz SA, et al. Genetic Risk Prediction of Atrial Fibrillation. Circulation. 2017;135(14):1311–20.
Mahajan R, et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. Eur Heart J. 2018;39(16):1407–15.
Manetas-Stavrakakis N, et al. Accuracy of artificial intelligence-based technologies for the diagnosis of atrial fibrillation: A systematic review and meta-analysis. J Clin Med. 2023;12(20):6576.
Marsili IA, et al. Implementation and validation of real-time algorithms for atrial fibrillation detection on a wearable ECG device. Comput Biol Med. 2020;116: 103540.
Ngufor C, et al. Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method. Am Heart J. 2023;260:124–40.
Article PubMed PubMed Central Google Scholar
Noseworthy PA, et al. Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial. Lancet. 2022a;400(10359):1206–12.
Noseworthy PA, et al. Percutaneous left atrial appendage occlusion in comparison to non-vitamin K antagonist oral anticoagulant among patients with atrial fibrillation. J Am Heart Assoc. 2022b;11(19):e027001.
Members WC, Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R. 2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2024 Jan 2;83(1):109–279. https://doi.org/10.1016/j.jacc.2023.08.017
O’Brien EC, et al. Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation. JAMA Intern Med. 2015;175(5):848–50.
Ong CJ, et al. Machine learning and natural language processing methods to identify ischemic stroke, acuity and location from radiology reports. PLoS One. 2020;15(6):e0234908.
Article CAS PubMed PubMed Central Google Scholar
Osmancik P, et al. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol. 2022;79(1):1–14.
Packer DL, et al. Effect of Catheter A
Comments (0)